These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 19285083)
1. Action potential clamp and chloroquine sensitivity of mutant Kir2.1 channels responsible for variant 3 short QT syndrome. El Harchi A; McPate MJ; Zhang Yh; Zhang H; Hancox JC J Mol Cell Cardiol; 2009 Nov; 47(5):743-7. PubMed ID: 19285083 [TBL] [Abstract][Full Text] [Related]
2. Chloroquine blocks a mutant Kir2.1 channel responsible for short QT syndrome and normalizes repolarization properties in silico. Lopez-Izquierdo A; Ponce-Balbuena D; Ferrer T; Sachse FB; Tristani-Firouzi M; Sanchez-Chapula JA Cell Physiol Biochem; 2009; 24(3-4):153-60. PubMed ID: 19710529 [TBL] [Abstract][Full Text] [Related]
3. Proarrhythmia in KCNJ2-linked short QT syndrome: insights from modelling. Adeniran I; El Harchi A; Hancox JC; Zhang H Cardiovasc Res; 2012 Apr; 94(1):66-76. PubMed ID: 22308236 [TBL] [Abstract][Full Text] [Related]
4. A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Priori SG; Pandit SV; Rivolta I; Berenfeld O; Ronchetti E; Dhamoon A; Napolitano C; Anumonwo J; di Barletta MR; Gudapakkam S; Bosi G; Stramba-Badiale M; Jalife J Circ Res; 2005 Apr; 96(7):800-7. PubMed ID: 15761194 [TBL] [Abstract][Full Text] [Related]
5. PA-6 inhibits inward rectifier currents carried by V93I and D172N gain-of-function K Ji Y; Veldhuis MG; Zandvoort J; Romunde FL; Houtman MJC; Duran K; van Haaften G; Zangerl-Plessl EM; Takanari H; Stary-Weinzinger A; van der Heyden MAG J Biomed Sci; 2017 Jul; 24(1):44. PubMed ID: 28711067 [TBL] [Abstract][Full Text] [Related]
6. Investigation of the Effects of the Short QT Syndrome D172N Kir2.1 Mutation on Ventricular Action Potential Profile Using Dynamic Clamp. Du C; Rasmusson RL; Bett GC; Franks B; Zhang H; Hancox JC Front Pharmacol; 2021; 12():794620. PubMed ID: 35115940 [TBL] [Abstract][Full Text] [Related]
7. Atrial arrhythmogenicity of KCNJ2 mutations in short QT syndrome: Insights from virtual human atria. Whittaker DG; Ni H; El Harchi A; Hancox JC; Zhang H PLoS Comput Biol; 2017 Jun; 13(6):e1005593. PubMed ID: 28609477 [TBL] [Abstract][Full Text] [Related]
8. Comparative effects of the short QT N588K mutation at 37 degrees C on hERG K+ channel current during ventricular, Purkinje fibre and atrial action potentials: an action potential clamp study. McPate MJ; Zhang H; Adeniran I; Cordeiro JM; Witchel HJ; Hancox JC J Physiol Pharmacol; 2009 Mar; 60(1):23-41. PubMed ID: 19439805 [TBL] [Abstract][Full Text] [Related]
10. Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study. Luo C; Wang K; Zhang H Biomed Eng Online; 2017 Jun; 16(1):69. PubMed ID: 28592292 [TBL] [Abstract][Full Text] [Related]
11. Action potential clamp and pharmacology of the variant 1 Short QT Syndrome T618I hERG K⁺ channel. El Harchi A; Melgari D; Zhang YH; Zhang H; Hancox JC PLoS One; 2012; 7(12):e52451. PubMed ID: 23300672 [TBL] [Abstract][Full Text] [Related]
12. Modelling the effects of quinidine, disopyramide, and E-4031 on short QT syndrome variant 3 in the human ventricles. Luo C; Wang K; Zhang H Physiol Meas; 2017 Sep; 38(10):1859-1873. PubMed ID: 28812984 [TBL] [Abstract][Full Text] [Related]
13. A novel gain-of-function KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents. Hattori T; Makiyama T; Akao M; Ehara E; Ohno S; Iguchi M; Nishio Y; Sasaki K; Itoh H; Yokode M; Kita T; Horie M; Kimura T Cardiovasc Res; 2012 Mar; 93(4):666-73. PubMed ID: 22155372 [TBL] [Abstract][Full Text] [Related]
14. Identification and functional characterisation of a novel KCNJ2 mutation, Val302del, causing Andersen-Tawil syndrome. Ördög B; Hategan L; Kovács M; Seprényi G; Kohajda Z; Nagy I; Hegedűs Z; Környei L; Jost N; Katona M; Szekeres M; Forster T; Papp JG; Varró A; Sepp R Can J Physiol Pharmacol; 2015 Jul; 93(7):569-75. PubMed ID: 26103554 [TBL] [Abstract][Full Text] [Related]
15. Hydrocinnamic Acid Inhibits the Currents of WT and SQT3 Syndrome-Related Mutants of Kir2.1 Channel. Ren S; Pang C; Huang Y; Xing C; Zhan Y; An H J Membr Biol; 2017 Oct; 250(5):425-432. PubMed ID: 28660286 [TBL] [Abstract][Full Text] [Related]
16. Electrophysiological and Pharmacological Characterization of Human Inwardly Rectifying K Sanson C; Schombert B; Filoche-Rommé B; Partiseti M; Bohme GA Assay Drug Dev Technol; 2019 Apr; 17(3):89-99. PubMed ID: 30835490 [TBL] [Abstract][Full Text] [Related]
17. Identification through action potential clamp of proarrhythmic consequences of the short QT syndrome T618I hERG 'hotspot' mutation. Du C; Zhang H; Harmer SC; Hancox JC Biochem Biophys Res Commun; 2022 Mar; 596():49-55. PubMed ID: 35114584 [TBL] [Abstract][Full Text] [Related]
18. Styrax blocks inward and outward current of Kir2.1 channel. Ren S; Pang C; Li J; Huang Y; Zhang S; Zhan Y; An H Channels (Austin); 2017 Jan; 11(1):46-54. PubMed ID: 27540685 [TBL] [Abstract][Full Text] [Related]
19. Modelling the effects of chloroquine on Luo C; Wang K; Zhang H Oncotarget; 2017 Dec; 8(63):106511-106526. PubMed ID: 29290967 [TBL] [Abstract][Full Text] [Related]
20. Ser165 in the second transmembrane region of the Kir2.1 channel determines its susceptibility to blockade by intracellular Mg2+. Fujiwara Y; Kubo Y J Gen Physiol; 2002 Nov; 120(5):677-93. PubMed ID: 12407079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]